Collegium Pharmaceutical's IPO

Collegium Pharmaceutical raised a round of funding on May 07, 2015. Investors include Public.

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chron…

Articles about Collegium Pharmaceutical's IPO: